CytoReason is an AI company developing a computational model of the human body, accurate enough to start replacing animal and human trials in drug development.
www.cytoreason.com
Location: Israel, Tel Aviv District, Tel Aviv-Yafo
Total raised: $20M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.09.2022 | - | $20M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 24.03.2022 | Poolbeg Pharma strikes deal with CytoReason for AI analysis | Clinical stage infectious disease pharmaceutical company Poolbeg Pharma has signed a deal with CytoR... | businesspl... |
| 10.02.2022 | CytoReason and Pfizer Extend Collaboration to Leverage Machi... | TEL AVIV, Israel, Feb. 10, 2022 /PRNewswire/ -- CytoReason, a leading developer of computational dis... | salamancap... |
| 21.10.2021 | CytoReason Collaborates With Merck On Cancer Immunotherapy D... | Using its proprietary computational disease models, CytoReason will help Merck understand the drug’s... | aithority.... |
| 30.09.2021 | CytoReason and Summit Pharmaceuticals International Announce... | TOKYO and TEL AVIV, Israel, Sept. 30, 2021 /PRNewswire/ -- CytoReason, an AI company developing comp... | salamancap... |
| 30.09.2021 | CytoReason and Summit Pharmaceuticals International Announce... | CytoReason, an AI company developing computational disease models for discovery and clinical drug de... | aithority.... |
| 17.06.2021 | CytoReason Collaborates With Sanofi, Using Its AI Technology... | The Focus of the Project Is to Tackle Asthma, a Major Chronic Condition Affecting More Than 340 Mill... | aithority.... |
| 19.05.2021 | CytoReason Announces Collaboration with Ferring to Identify ... | TEL AVIV, Israel, May 19, 2021 /PRNewswire/ -- CytoReason, an Israeli company developing a computa... | prnewswire... |
| 17.05.2021 | Code Ocean Announces $21 Million in Funding to Accelerate in... | Code Ocean has raised $21 million to accclerate development of its leading computational research en... | prweb.com/... |
| 11.03.2019 | Ground Breaking New Methodology Published in Nature Medicine... | There is the age you say you are – which is not always accurate but always medically irrelevant. Th... | venturebea... |
| 07.01.2019 | CytoReason Signs Collaboration Agreement with Pfizer Inc. To... | TEL AVIV, Israel–(BUSINESS WIRE)–January 7, 2019– CytoReason, a leader in machine learning for drug... | venturebea... |
Show more